Soreness After Deep Dry Needling of One Latent Myofascial Trigger Point

Pain After Dry Needling Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02158104
• Other study ID #: CEU-004
• Status: Completed
• Phase: Phase 2/Phase 3
• First received: June 5, 2014
• Last updated: June 5, 2014
• Start date: October 2013

Study information

• Verified date: January 2014
• Source: CEU San Pablo University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Pain after dry needling or injection in the muscle is a frequent secondary effect in the treatment of myofascial pain syndrome. In this trial pain and sensitivity will be assessed during a 72 hours follow up period. Factors that may contribute to higher levels of pain or sensitivity will be evaluated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. primary completion date: February 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

The latent MTrP diagnosis was based upon the following criteria:10

1. presence of a palpable taut band in the muscle

2. presence of a hypersensitive tender spot in the taut band

3. palpable or visible local twitch response with snapping palpation of the tout band

4. referred pain elicitation in response to compression.

Exclusion Criteria:

1. presence of coagulation disorders

2. neck or facial pain

3. previous application of a dry needling technique

4. MTrP therapy in head or neck within the previous 3 months

5. fibromyalgia

6. an insurmountable fear of needles as a reason of refusing the treatment

7. history of surgery in the head or neck area.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pain After Dry Needling

Intervention

Procedure:
• Deep dry needling

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
CEU San Pablo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain	Visual analogue scale	72 hours	Yes
Secondary	Sensitivity	Pressure pain threshold	72 hours	Yes